Skip to Content

KADIAN 200 mg (Morphine Sulfate Extended Release 200 mg)

Pill with imprint KADIAN 200 mg is Brown, Capsule-shape and has been identified as Morphine Sulfate Extended Release 200 mg. It is supplied by Actavis.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 200 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for KADIAN 200 mg

Morphine Sulfate Extended Release

Imprint:
KADIAN 200 mg
Strength:
200 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Actavis
National Drug Code (NDC):
00228-3508

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide